Mike Muhlfelder

The UAE and Saudi Arabia are investing billions in US AI infrastructure. The deals could help the US in the AI race against China.

Silicon Valley’s coveted work visas are under heavy scrutiny from the Trump administration, and immigration lawyers say requests for documentation are increasing.

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 medication injected daily instead of weekly.

In response to X user queries about everything from sports to Medicaid cuts, the xAI chatbot inserted unrelated information about “white genocide” in South Africa.

Microsoft is limiting access to tools that boosted its rivals, but larger customers like DuckDuckGo say they won’t be affected.